Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
USP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDLIM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GIPC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
JPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF10D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAMPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PUS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INSC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCSK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on